Brian Nowosielski

Check out this list of our top 5 most read women’s health stories from the year 2024.

Check out this list of our top 5 most read infectious disease stories from the year 2024.

Check out this list of our top 5 most read pain management stories from the year 2024.

Check out this list of our top 5 most read cardiology stories from the year 2024.

Check out this list of our top 5 most read digestive health stories from the year 2024.

Check out this list of our top 5 most read Total Pharmacy stories from the year 2024.

Check out this list of our top 5 most read COVID-19 stories from the year 2024.

Check out this list of our top 5 most read Drug Topics stories from the year 2024.

Provisions under the Inflation Reduction Act have ensured cost savings for patients prescribed drugs covered under Medicare Part B.

Senators Elizabeth Warren and Tina Smith have reintroduced the Pharmaceutical Supply Chain Defense and Enhancement Act originally established in 2020.

Researchers reviewed Medicaid policies to understand vaccine coverage and reimbursement rates among physicians and pharmacists.

Researchers explored the impacts of natural bioactive compounds for the treatment of acute pancreatitis.

With pressure from the House GOP, expected PBM reform was not included in Congress’ end-of-year spending package.

Recent upticks of the bird flu virus in both dairy cattle and humans have also led to a state of emergency in California.

The American Pharmacists Association announced the inclusion of pharmacist-backed PBM reform in Congress’ end of the year spending package.

Drug Topics met with Lourdes Cross, PharmD, BCACP, CDCES, to discuss pharmacists’ role in managing patients’ chronic obstructive pulmonary disease.

Experts conducted a study to better understand how ambulatory care pharmacist services impacted patient outcomes, provider workload, and access to care.

Drug Topics met with Amanuel Kehasse, PharmD, PhD, to discuss the barriers surrounding biosimilar implementation in the prescription drug market.

See what’s trending in pharmacy with a preview of the Total Pharmacy December issue.

Denise Kelley, PharmD, BCPS, FASHP, joined Drug Topics to discuss various medications for chronic kidney disease and their common adverse reactions.

Kathryn Litten, PharmD, discussed the pharmacist’s role in helping patients manage metabolic dysfunction-associated steatotic liver disease.

US Senators introduced the bipartisan bill addressing pharmacy benefit managers and their affiliated pharmacies.

Lourdes Cross, PharmD, BCACP, CDCES, discussed chronic obstructive pulmonary disease and how pharmacists are positioned to help patients’ exacerbations.

Researchers presented the community-wide benefits of a collaborative pharmacy-driven vaccine clinic in an urban setting.

Amanuel Kehasse, PharmD, PhD, explored reasons why patients and providers may be avoiding the implementation of biosimilar medications.

Lisa Faast, PharmD, discusses how to use technology to innovate within the pharmacy.

John Bucheit, PharmD, joined Drug Topics to discuss statins and nonstatins’ efficacy in treating cardiovascular disease.

Denise Kelley, PharmD, BCPS, FASHP, discussed the efficacy of medications designed to treat the progression of chronic kidney disease.

Kathryn Litten, PharmD, joined Drug Topics to discuss how pharmacists can counsel patients with metabolic dysfunction-associated steatotic liver disease.

See what’s trending in pharmacy with a preview of the Drug Topics November/December issue.